Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02863393|
Recruitment Status : Withdrawn (Couldnt find sponor for this study)
First Posted : August 11, 2016
Last Update Posted : August 30, 2017
|Condition or disease||Intervention/treatment||Phase|
|Non-alcoholic Fatty Liver Disease||Other: Diaphragmatic breathing exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Intentional Diaphragmatic Breathing Exercise Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)|
|Actual Study Start Date :||August 29, 2017|
|Estimated Primary Completion Date :||January 2018|
|Estimated Study Completion Date :||March 2018|
Experimental: Diaphragmatic breathing exercise
The aim of this study is to ameliorate hepatic inflammation by using diaphragmatic breathing exercises instead of aerobic exercise to reduce the fat in liver inflammation.
Other: Diaphragmatic breathing exercise
Through diaphragmatic breathing exercise to verify the impact of this item interventions on patients' metabolism indicators.
- AST and ALT [ Time Frame: Up to 3 months to collect data ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02863393
|Study Director:||Ming-Shun Wu, Doctor||Wanfang Hospital|